1. Home
  2. USGO vs RPID Comparison

USGO vs RPID Comparison

Compare USGO & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U.S. GoldMining Inc.

USGO

U.S. GoldMining Inc.

HOLD

Current Price

$9.20

Market Cap

104.5M

ML Signal

HOLD

Logo Rapid Micro Biosystems Inc.

RPID

Rapid Micro Biosystems Inc.

HOLD

Current Price

$1.66

Market Cap

84.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USGO
RPID
Founded
2015
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Medical Specialities
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
104.5M
84.8M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
USGO
RPID
Price
$9.20
$1.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$30.75
$8.00
AVG Volume (30 Days)
66.2K
222.2K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
19.12
2.78
EPS
N/A
N/A
Revenue
N/A
$33,587,000.00
Revenue This Year
N/A
$19.12
Revenue Next Year
N/A
$18.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.74
52 Week Low
$7.16
$1.52
52 Week High
$17.98
$4.94

Technical Indicators

Market Signals
Indicator
USGO
RPID
Relative Strength Index (RSI) 64.43 38.58
Support Level $8.73 N/A
Resistance Level $10.50 $2.18
Average True Range (ATR) 0.49 0.14
MACD 0.13 -0.03
Stochastic Oscillator 82.00 20.59

Price Performance

Historical Comparison
USGO
RPID

About USGO U.S. GoldMining Inc.

US Goldmining Inc is a mineral exploration company with a focus on the exploration and development of a project located in Alaska, USA. The company's primary asset is the 100%-owned Whistler exploration property located in Alaska, USA. It operates and reports in one segment, which focuses on the exploration and development of mineral properties.

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.

Share on Social Networks: